VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $35,666,000 | +57.0% | 1,534,677 | +7.6% | 0.03% | +54.5% |
| Q1 2018 | $22,712,000 | -15.3% | 1,426,661 | +10.6% | 0.02% | -18.5% |
| Q4 2017 | $26,807,000 | +90.7% | 1,290,027 | +31.5% | 0.03% | +80.0% |
| Q3 2017 | $14,057,000 | +0.6% | 980,919 | +21.5% | 0.02% | -11.8% |
| Q2 2017 | $13,967,000 | +204.8% | 807,319 | +94.3% | 0.02% | +142.9% |
| Q1 2017 | $4,582,000 | +59.2% | 415,402 | +109.6% | 0.01% | +75.0% |
| Q4 2016 | $2,878,000 | -5.6% | 198,224 | +59.6% | 0.00% | -20.0% |
| Q3 2016 | $3,048,000 | +291.8% | 124,173 | +221.5% | 0.01% | +400.0% |
| Q2 2016 | $778,000 | -94.8% | 38,620 | -93.2% | 0.00% | -95.8% |
| Q1 2016 | $14,832,000 | -70.3% | 563,955 | +14.8% | 0.02% | -71.8% |
| Q4 2015 | $49,923,000 | -38.7% | 491,125 | +7.5% | 0.08% | -46.5% |
| Q3 2015 | $81,471,000 | +129.1% | 456,727 | +185.3% | 0.16% | +130.4% |
| Q2 2015 | $35,565,000 | +13.9% | 160,095 | +1.9% | 0.07% | +9.5% |
| Q1 2015 | $31,217,000 | +202.9% | 157,170 | +118.2% | 0.06% | +186.4% |
| Q4 2014 | $10,306,000 | -17.0% | 72,015 | -23.9% | 0.02% | -18.5% |
| Q3 2014 | $12,413,000 | +40.1% | 94,613 | +34.7% | 0.03% | +35.0% |
| Q2 2014 | $8,859,000 | +24.2% | 70,243 | +29.8% | 0.02% | +17.6% |
| Q1 2014 | $7,132,000 | +11.6% | 54,099 | -0.6% | 0.02% | +13.3% |
| Q4 2013 | $6,391,000 | +2.7% | 54,439 | -8.8% | 0.02% | -11.8% |
| Q3 2013 | $6,226,000 | +19.1% | 59,676 | -1.7% | 0.02% | +13.3% |
| Q2 2013 | $5,226,000 | – | 60,713 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |